CARMICHAEL GREG D

SEC source: 0000785161-26-000164 · form4.xml · nonDerivative · entry 1

CARMICHAEL GREG D · CIK 0001247734 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,349

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 15, 2026, Encompass Health paid a dividend on its common stock of $0.19 per share and the closing price was $109.88. The transaction reported on this Form 4 is an award of RSUs as sociated with that dividend payment.

SEC source: 0000785161-26-000140 · form4.xml · nonDerivative · entry 1

CARMICHAEL GREG D · CIK 0001247734 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,320

F1 · shares: Annual grant of restricted stock units pursuant to the Corporation's 2025 Omnibus Performance Incentive Plan.

SEC source: 0000785161-26-000125 · form4.xml · nonDerivative · entry 1

CARMICHAEL GREG D · CIK 0001247734 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,686

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2026, Encompass Health paid a dividend on its common stock of $0.19 per share and the closing price was $105.24. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0000785161-26-000016 · form4.xml · nonDerivative · entry 1

CARMICHAEL GREG D · CIK 0001247734 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,659

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 15, 2026, Encompass Health paid a dividend on its common stock of $0.19 per share and the closing price was $102.80. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0000785161-25-000110 · form4.xml · nonDerivative · entry 1

CARMICHAEL GREG D · CIK 0001247734 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,631

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 15, 2025, Encompass Health paid a dividend on its common stock of $0.19 per share and the closing price was $123.65. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-25-019243 · form4.xml · nonDerivative · entry 1

CARMICHAEL GREG D · CIK 0001247734 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,608

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 15, 2025, Encompass Health paid a dividend on its common stock of $0.17 per share and the closing price was $107.28. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-25-013143 · form4.xml · nonDerivative · entry 1

CARMICHAEL GREG D · CIK 0001247734 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,584

F1 · shares: Annual grant of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

SEC source: 0001127602-25-012148 · form4.xml · nonDerivative · entry 1

CARMICHAEL GREG D · CIK 0001247734 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,160

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2025, Encompass Health paid a dividend on its common stock of $0.17 per share and the closing price was $102.30. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-25-001397 · form4.xml · nonDerivative · entry 1

CARMICHAEL GREG D · CIK 0001247734 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,137

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 15, 2025, Encompass Health paid a dividend on its common stock of $0.17 per share and the closing price was $93.61. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-24-025653 · form4.xml · nonDerivative · entry 4

CARMICHAEL GREG D · CIK 0001247734 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,112

F2 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 15, 2024, Encompass Health paid a dividend on its common stock of $0.17 per share and the closing price was $96.33. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-24-020548 · form4.xml · nonDerivative · entry 1

CARMICHAEL GREG D · CIK 0001247734 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,074

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 15, 2024, Encompass Health paid a dividend on its common stock of $0.15 per share and the closing price was $85.49. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-24-025653 · form4.xml · nonDerivative · entry 3

CARMICHAEL GREG D · CIK 0001247734 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,088

F1 · shares: This acquisition is a dividend reinvestment administered by the reporting person's broker. It is eligible for deferred reporting on Form 5 pursuant to Rule 16a-6 but is being reported earlier than required on Form 4.

SEC source: 0001127602-24-014368 · form4.xml · nonDerivative · entry 1

CARMICHAEL GREG D · CIK 0001247734 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,050

SEC source: 0001127602-24-014065 · form4.xml · nonDerivative · entry 1

CARMICHAEL GREG D · CIK 0001247734 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,050

F1 · shares: Annual grant of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

SEC source: 0001127602-24-013003 · form4.xml · nonDerivative · entry 1

CARMICHAEL GREG D · CIK 0001247734 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,072

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2024, Encompass Health paid a dividend on its common stock of $0.15 per share and the closing price was $80.73. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-24-025653 · form4.xml · nonDerivative · entry 2

CARMICHAEL GREG D · CIK 0001247734 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,079

F1 · shares: This acquisition is a dividend reinvestment administered by the reporting person's broker. It is eligible for deferred reporting on Form 5 pursuant to Rule 16a-6 but is being reported earlier than required on Form 4.

SEC source: 0001127602-24-001404 · form4.xml · nonDerivative · entry 1

CARMICHAEL GREG D · CIK 0001247734 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,051

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 16, 2024, Encompass Health paid a dividend on its common stock of $0.15 per share and the closing price was $71.45. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-24-025653 · form4.xml · nonDerivative · entry 1

CARMICHAEL GREG D · CIK 0001247734 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,055

F1 · shares: This acquisition is a dividend reinvestment administered by the reporting person's broker. It is eligible for deferred reporting on Form 5 pursuant to Rule 16a-6 but is being reported earlier than required on Form 4.

SEC source: 0001127602-23-026009 · form4.xml · nonDerivative · entry 1

CARMICHAEL GREG D · CIK 0001247734 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,027

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 16, 2023, Encompass Health paid a dividend on its common stock of $0.15 per share and the closing price was $63.77. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-23-020898 · form4.xml · nonDerivative · entry 1

CARMICHAEL GREG D · CIK 0001247734 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,000

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 17, 2023, Encompass Health paid a dividend on its common stock of $0.15 per share and the closing price was $67.54. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-23-014809 · form4.xml · nonDerivative · entry 1

CARMICHAEL GREG D · CIK 0001247734 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,975

F1 · shares: Annual grant of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

SEC source: 0001127602-23-013202 · form4.xml · nonDerivative · entry 1

CARMICHAEL GREG D · CIK 0001247734 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,590

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 17, 2023, Encompass Health paid a dividend on its common stock of $0.15 per share and the closing price was $61.39. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0000035527-23-000111 · wf-form4_167701479110942.xml · nonDerivative · entry 2

CARMICHAEL GREG D · CIK 0001247734 · Director · Executive Chair

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 826,355

F2 · kind: Shares withheld for taxes upon the vesting of restricted stock units granted to the reporting person on February 17, 2021.

SEC source: 0000035527-23-000111 · wf-form4_167701479110942.xml · nonDerivative · entry 1

CARMICHAEL GREG D · CIK 0001247734 · Director · Executive Chair

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 835,024

F1 · kind: Shares withheld for taxes upon the vesting of restricted stock units granted to the reporting person on February 16, 2022.

SEC source: 0000035527-23-000079 · wf-form4_167659375097191.xml · nonDerivative · entry 2

CARMICHAEL GREG D · CIK 0001247734 · Director · Executive Chair

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 717,755

F2 · security: Shares withheld for taxes upon the vesting performance shares granted to the reporting person.

SEC source: 0000035527-23-000079 · wf-form4_167659375097191.xml · nonDerivative · entry 1

CARMICHAEL GREG D · CIK 0001247734 · Director · Executive Chair

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 777,756

F1 · security: Performance Share award received upon satisfaction of performance criteria subject to vesting on February 15, 2023.

SEC source: 0000035527-23-000079 · wf-form4_167659375097191.xml · nonDerivative · entry 3

CARMICHAEL GREG D · CIK 0001247734 · Director · Executive Chair

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 842,394

F3 · security: Restricted Stock Units granted pursuant to Fifth Third Bancorp Incentive Compensation Plan subject to vesting in four equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0000035527-23-000045 · wf-form4_167641049621057.xml · nonDerivative · entry 1

CARMICHAEL GREG D · CIK 0001247734 · Director · Executive Chair

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 638,586

F1 · kind: Shares withheld for taxes upon the vesting of restricted stock units granted to the reporting person on February 12, 2020.

SEC source: 0001127602-23-001751 · form4.xml · nonDerivative · entry 1

CARMICHAEL GREG D · CIK 0001247734 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,568

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 17, 2023, Encompass Health paid a dividend on its common stock of $0.15 per share and the closing price was $61.16. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-22-024569 · form4.xml · nonDerivative · entry 1

CARMICHAEL GREG D · CIK 0001247734 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,546

SEC source: 0001127602-22-024109 · form4.xml · nonDerivative · entry 1

CARMICHAEL GREG D · CIK 0001247734 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,716

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 17, 2022, Encompass Health paid a dividend on its common stock of $0.15 per share and the closing price was $48.81. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-22-019589 · form4.xml · nonDerivative · entry 1

CARMICHAEL GREG D · CIK 0001247734 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,723

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 20, 2022, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $49.19. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-22-013820 · form4.xml · nonDerivative · entry 1

CARMICHAEL GREG D · CIK 0001247734 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,173

F1 · shares: Annual grant of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

SEC source: 0000035527-22-000177 · wf-form4_165065778897315.xml · nonDerivative · entry 1

CARMICHAEL GREG D · CIK 0001247734 · Director · CEO, Chair

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 644,745

F1 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.04 to $40.08, inclusive. The reporting person undertakes to provide to Fifth Third Bancorp, any of its security holders or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

SEC source: 0001127602-22-012235 · form4.xml · nonDerivative · entry 1

CARMICHAEL GREG D · CIK 0001247734 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,947

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 18, 2022, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $71.41. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0000035527-22-000097 · wf-form4_164522295980871.xml · nonDerivative · entry 4

CARMICHAEL GREG D · CIK 0001247734 · Director · CEO, Chair

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 694,745

F4 · kind: Shares withheld for taxes upon the vesting of restricted stock units granted to the reporting person on February 17, 2021.

SEC source: 0000035527-22-000097 · wf-form4_164522295980871.xml · derivative · entry 5

CARMICHAEL GREG D · CIK 0001247734 · Director · CEO, Chair

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,451

Underlying: Common Stock · 76,451 shares

Expires 2032-02-16

F6 · price: Granted pursuant to Fifth Third Bancorp Incentive Compensation Plan. No consideration paid.

F5 · derivative.exercise_date: Indicates grant date. Stock appreciation rights are exercisable in thirds beginning on the first anniversary of the grant date with one-third of the total grant vesting annually over a three-year period.

SEC source: 0000035527-22-000097 · wf-form4_164522295980871.xml · nonDerivative · entry 3

CARMICHAEL GREG D · CIK 0001247734 · Director · CEO, Chair

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 703,784

F3 · security: Restricted Stock granted pursuant to Fifth Third Bancorp Incentive Compensation Plan subject to vesting in three equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0000035527-22-000097 · wf-form4_164522295980871.xml · nonDerivative · entry 2

CARMICHAEL GREG D · CIK 0001247734 · Director · CEO, Chair

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 652,752

F2 · security: Shares withheld for taxes upon the vesting performance shares granted to the reporting person.

SEC source: 0000035527-22-000097 · wf-form4_164522295980871.xml · nonDerivative · entry 1

CARMICHAEL GREG D · CIK 0001247734 · Director · CEO, Chair

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 712,666

F1 · security: Performance Share award received upon satisfaction of performance criteria subject to vesting on February 16, 2022.

SEC source: 0000035527-22-000069 · wf-form4_164496073766164.xml · nonDerivative · entry 1

CARMICHAEL GREG D · CIK 0001247734 · Director · CEO, Chair

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 580,040

F1 · kind: Shares withheld for taxes upon the vesting of restricted stock units granted to the reporting person on February 12, 2020.

SEC source: 0000035527-22-000053 · wf-form4_164444177586999.xml · nonDerivative · entry 3

CARMICHAEL GREG D · CIK 0001247734 · Director · CEO, Chair

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 589,820

F1 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $49.10 to $49.38, inclusive. The reporting person undertakes to provide to Fifth Third Bancorp, any of its security holders or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

SEC source: 0000035527-22-000053 · wf-form4_164444177586999.xml · derivative · entry 4

CARMICHAEL GREG D · CIK 0001247734 · Director · CEO, Chair

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 141,447 shares

Expires 2023-04-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · price: Granted pursuant to Fifth Third Bancorp Incentive Compensation Plan. No consideration paid.

F2 · derivative.exercise_date: Indicates grant date. Stock appreciation rights are exercisable in fourths beginning on the first anniversary of the grant date with one-fourth of the total grant vesting annually over a four-year period.

SEC source: 0000035527-22-000053 · wf-form4_164444177586999.xml · nonDerivative · entry 2

CARMICHAEL GREG D · CIK 0001247734 · Director · CEO, Chair

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 657,507

SEC source: 0000035527-22-000053 · wf-form4_164444177586999.xml · nonDerivative · entry 1

CARMICHAEL GREG D · CIK 0001247734 · Director · CEO, Chair

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 745,630

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000035527-22-000037 · wf-form4_164435503608099.xml · nonDerivative · entry 1

CARMICHAEL GREG D · CIK 0001247734 · Director · CEO, Chair

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 604,183

F1 · kind: Shares withheld for taxes upon the vesting of restricted stock units granted to the reporting person on February 6, 2019.

SEC source: 0001127602-22-001725 · form4.xml · nonDerivative · entry 1

CARMICHAEL GREG D · CIK 0001247734 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,927

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 18, 2022, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $61.63. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0000035527-21-000269 · wf-form4_164003681847028.xml · nonDerivative · entry 1

CARMICHAEL GREG D · CIK 0001247734 · Director · CEO, Chair

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 616,018

SEC source: 0001127602-21-027248 · form4.xml · nonDerivative · entry 1

CARMICHAEL GREG D · CIK 0001247734 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,904

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 15, 2021, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $67.62. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-21-022092 · form4.xml · nonDerivative · entry 1

CARMICHAEL GREG D · CIK 0001247734 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,883

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 15, 2021, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $79.89. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.